News

Gene therapy for cystic fibrosis is advancing fast. Explore key biotech players, clinical progress, and its potential to ...
University of Florida scientists have helped identify a novel drug compound that selectively activates pain-altering ...
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report ...
Prescription Drug User Fee Act (PDUFA) goal date of August 27, 2025 ISELIN, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc.
Novo Nordisk NVO and Eli Lilly LLY dominate the diabetes and obesity market on the back of the tremendous success of their ...